News
Migraine treatment with topiramate is linked to lower risks of end-stage kidney disease (ESKD), death, and ventricular arrhythmia/cardiac arrest, an investigator reported at the 62 nd European Renal ...
Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...
S.F. Holding Co., Ltd. (002352.SZ; 06936.HK, 'SF Holding', 'SF' or the 'the Company') announced a USD 376 million H-share equity placement and concurrent USD 376 million offering of 363-day ...
Background and objective Diabetes is a strong risk factor for cardiovascular diseases, whereas few studies have investigated simultaneously the associations of glycated haemoglobin A1c (HbA1c), ...
The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.
5d
Vietnam Investment Review on MSNBioCity s SC0062 wins breakthrough status for kidney disease treatmentBioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...
7d
MedPage Today on MSNMicroplastic-Water Risks; Predictive Sit-Rise Test; Bioresorbable Scaffold SetbackThe Magmaris bioresorbable scaffold was associated with a high restenosis rate 5 years into the MAGSTEMI trial, so a new ...
Albuminuria: Albuminuria is present in ≈9.5% of US adults. 67: Albuminuria is strongly and independently associated with multiple adverse outcomes, including death, cardiovascular events, and kidney ...
Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...
A smartphone-based home albuminuria test facilitates screening and early diagnosis of kidney disease in high-risk individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results